BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/14/2017 6:51:01 PM | Browse: 972 | Download: 1636
 |
Received |
|
2016-11-16 11:07 |
|
Peer-Review Started |
|
2016-11-17 18:00 |
|
To Make the First Decision |
|
2016-12-19 09:53 |
|
Return for Revision |
|
2016-12-24 18:04 |
|
Revised |
|
2017-01-06 21:49 |
|
Second Decision |
|
2017-03-01 11:09 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2017-03-02 16:55 |
|
Articles in Press |
|
2017-03-02 16:55 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2017-03-22 04:41 |
|
Typeset the Manuscript |
|
2017-03-29 12:33 |
|
Publish the Manuscript Online |
|
2017-04-14 18:51 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Geriatrics & Gerontology |
| Manuscript Type |
Basic Study |
| Article Title |
Berberine displays antitumor activity in esophageal cancer cells in vitro
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shu-Xian Jiang, Bo Qi, Wen-Jian Yao, Cheng-Wei Gu, Xiu-Feng Wei, Yi Zhao, Yu-Zhen Liu and Bao-Sheng Zhao |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Key Technologies R&D Program of Science and Technology Commission of Henan Province |
52102310110 |
| Key Science and Technique Fund of Xinxiang |
ZG15018 |
|
| Corresponding Author |
Bao-Sheng Zhao, MD, Professor, Chief, Department of Thoracic Surgery, The First Affiliated Hospital of Xinxiang Medical University, Weihui 453100, Henan Province,
China. zhaobscn@126.com |
| Key Words |
Berberine; Esophageal cancer; Antitumor activity; Proliferation; Cell cycle; Apoptosis |
| Core Tip |
Initial diagnosis of many esophageal cancer (EC) patients is made at an advanced stage of the disease, making surgery an undesirable option. Although advances in chemotherapy have been achieved, serious adverse effects usually limit clinical application. Exploring non-invasive strategies to prevent the growth of EC is urgently needed. The current research showed that berberine is an inhibitor of human EC cell growth and could be considered as a potential source of drugs for the treatment of EC patients. |
| Publish Date |
2017-04-14 18:51 |
| Citation |
Jiang SX, Qi B, Yao WJ, Gu CW, Wei XF, Zhao Y, Liu YZ, Zhao BS. Berberine displays antitumor activity in esophageal cancer cells in vitro. World J Gastroenterol 2017; 23(14): 2511-2518 |
| URL |
http://www.wjgnet.com/1007-9327/full/ v23/i14/2511.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v23.i14.2511 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
